TEAMFund

TEAMFund (Transforming Equity and Access in MedTech) is a global-health impact investor and advisor founded in 2016, with a US base in San Francisco, California. It runs a distinctive hybrid structure that couples a for-profit impact investment fund with a non-profit programming arm; the non-profit informs investments through rigorous research and provides portfolio companies with wraparound support, drawing on an 80-plus worldwide team of executive-level advisors and CEOs from leading healthcare multinationals. Its mission is to expand access to affordable, appropriate and sustainable medical technologies, digital health and facilitating technologies that address unmet health needs in resource-constrained, underserved populations, with a thesis that non-communicable diseases pose the greatest threat in low- and middle-income countries. The firm invests in commercial-stage companies and focuses geographically on India and Sub-Saharan Africa, where local entrepreneurs are often best positioned to close care gaps, typically as a co-investor. TEAMFund closed its inaugural $30M impact fund in 2019, structured with a 10-year horizon and a plan for 8 to 10 portfolio companies, and has since raised a follow-on Impact Fund II. It is co-founded and co-chaired by Tim Ring, former Chairman and CEO of C.R. Bard, and Kathryn Gleason, former senior partner at Morgan Lewis, and led day-to-day by Managing Partner Yousuf Mazhar. Portfolio companies include Qure.ai, MediBuddy, Tricog Health, Forus Health, JanaCare, EchoNous and Vezeeta, which collectively delivered tens of millions of patient services. Its most recent tracked activity was participation in Qure.ai's $65M Series D in September 2024. TEAMFund pairs impact capital with deep medtech advisory support.